These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28040662)

  • 21. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
    Jeong D; Bae BC; Park SJ; Na K
    J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.
    Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY; Chung SJ; Cho HJ; Kim DD
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
    Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
    Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: Optimization and modelling of doxorubicin release.
    Soares PIP; Sousa AI; Ferreira IMM; Novo CMM; Borges JP
    Carbohydr Polym; 2016 Nov; 153():212-221. PubMed ID: 27561489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.
    Wang B; Yuan Y; Han L; Ye L; Shi X; Feng M
    J Drug Target; 2014 Jan; 22(1):76-85. PubMed ID: 24093636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma.
    Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL
    Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
    Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
    J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
    Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.
    Tan ML; Friedhuber AM; Dunstan DE; Choong PF; Dass CR
    Biomaterials; 2010 Jan; 31(3):541-51. PubMed ID: 19836833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
    Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q
    J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.
    Ma Z; He H; Sun F; Xu Y; Huang X; Ma Y; Zhao H; Wang Y; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1929-1940. PubMed ID: 28536738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
    Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
    Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
    Xu SS; Wu J; Jiang W
    J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy.
    Ye PJ; Huang C; Yang S; Gao P; Li ZP; Tang SY; Xiang Y; Liu YF; Chen YP; He DX; Yu CY
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S661-S670. PubMed ID: 30307317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.